Cara Therapeutics, Inc. operates as a biopharmaceutical company that focuses on developing and commercializing therapeutics treatment of chronic pruritus in the...
Careteq Completes Sale of Embedded Health Unit to Fund Platform Growth and Strengthen Balance Sheet
Carasent Sets 14 April Date for Q1 2026 Results and Webcast
Carma issues new shares under employee incentive plan and confirms compliance
Carma Director Owen Wilson Lifts Stake with On-Market Share Purchases
Carasent Nomination Committee Proposes Unchanged Board Line-Up for 2026 AGM